Capstone Holding Corp. — Director's Dealing 2016

Jan 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2016-01-22

Reporting Person: HOWSE ELWOOD D (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-22	Stock Option (Right to Buy)	$0.10	A	50000	Acquired	2026-01-22	Common Stock (50000)	Direct